Foteini Violitzi
Overview
Explore the profile of Foteini Violitzi including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
5
Citations
50
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Perivolidi V, Violitzi F, Ioannidou E, Rinotas V, Stamatakis G, Samiotaki M, et al.
J Proteome Res
. 2022 Jan;
21(2):375-394.
PMID: 34983179
The outer mitochondrial membrane protein SLC25A46 has been recently identified as a novel genetic cause of a wide spectrum of neurological diseases. The aim of the present work was to...
2.
Rinotas V, Papakyriakou A, Violitzi F, Papaneophytou C, Ouzouni M, Alexiou P, et al.
J Med Chem
. 2020 Sep;
63(20):12043-12059.
PMID: 32955874
Receptor activator of nuclear factor-κB ligand (RANKL) constitutes the master mediator of osteoclastogenesis, while its pharmaceutical inhibition by a monoclonal antibody has been approved for the treatment of postmenopausal osteoporosis....
3.
Violitzi F, Perivolidi V, Thireou T, Grivas I, Haralambous S, Samiotaki M, et al.
J Proteome Res
. 2019 Sep;
18(11):3896-3912.
PMID: 31550165
We previously identified DNAJC11, a mitochondrial outer membrane protein of unknown function, as a novel genetic cause in modeled neuromuscular disease. To understand the physiological role of DNAJC11, we employed...
4.
Papadaki M, Rinotas V, Violitzi F, Thireou T, Panayotou G, Samiotaki M, et al.
Front Immunol
. 2019 Feb;
10:97.
PMID: 30804932
Receptor activator of nuclear factor-κB ligand (RANKL), a member of the Tumor Necrosis Factor (TNF) superfamily, constitutes the master regulator of osteoclast formation and bone resorption, whereas its involvement in...
5.
Ioakeimidis F, Ott C, Kozjak-Pavlovic V, Violitzi F, Rinotas V, Makrinou E, et al.
PLoS One
. 2014 Aug;
9(8):e104237.
PMID: 25111180
Mitochondrial structure and function is emerging as a major contributor to neuromuscular disease, highlighting the need for the complete elucidation of the underlying molecular and pathophysiological mechanisms. Following a forward...